NEW YORK (GenomeWeb) – Horizon Discovery Group and Abcam today announced a licensing and supply agreement that gives Abcam exclusive access to more than 1,800 human diploid and haploid cell lines from Horizon's X-MAN collection. 

The cell lines will help in the validation of Abcam's existing monoclonal and polyclonal antibodies marketed to researchers, the firms said, and Horizon will develop additional haploid cell lines to validate new antibodies from Abcam. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.